You are now leaving the pages of www.gilead.com intended for U.S. audiences. The information in this section is intended for visitors outside the United States.
Praça Duque de Saldanha, nº1 – 8ºA e B
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
Gilead in Portugal has been in operation since February 1996. When the company first began operating, it was called Nexstar Farmacêutica Lda., and then in 2001 officially became Gilead Sciences Lda. Gilead's office in Lisbon provides sales, marketing, medical and regulatory support for Gilead's products throughout Portugal.
Gilead provided support to the following healthcare and research organizations via unrestricted grants and provided financial support and/or significant indirect/non-financial support to the following patient organizations in 2012. The information is subject to change and will be updated accordingly.
The information on the grants given by Gilead Sciences, Lda. to the Patients’ Organizations listed herein is available upon request by any interested party.
This page is intended for visitors outside of the United States.